Together, these results indicate that nicotine-induced α9-nAChR activity activates the STAT3 signaling pathway that influences melanoma cell proliferation and upregulates PD-L1 expression, and the STAT3 inhibitors Stattic and NSC74859 prevent nicotine-induced PD-L1 expression and proliferation. Here, STAT3 is linked to melanoma.